Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)

This study is ongoing, but not recruiting participants.

Study NCT00113347 Information provided by M.D. Anderson Cancer Center

First Received: June 7, 2005 Last Updated: May 29, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	April 2010
Primary Completion Date:	October 2008 (Final data collection date for primary outcome measure)